P. S. Dragovich et al. / Tetrahedron: Asymmetry 19 (2008) 2796–2803
2803
1996, 61, 5557; (i) Davies, S. G.; Ichihara, O.; Walters, I. A. S. Synlett 1993, 461;
(j) Konosu, T.; Oida, S. Chem. Pharm. Bull. 1993, 41, 1012.
3.00 (1H, dd, J = 14.7, 7.6), 4.10 (2H, q, J = 7.2), 4.22–4.34 (1H, m),
5.09 (2H, s), 5.20–5.31 (1H, m), 7.28–7.40 (5H, m); 13C NMR
(CDCl3): d: 14.4, 22.4, 28.1, 32.5, 46.9, 54.3, 60.7, 66.8, 128.0,
128.1, 128.5, 136.5, 155.7, 174.2; Anal. Calcd for C16H21NO4: C,
65.96; H, 7.27; N, 4.81. Found: C, 65.94; H, 7.32; N, 4.88.
9. For reviews summarizing the preparation and utilization of 2-
aminocycloalkane carboxylic acids, see: (a) Fülöp, F.; Martinek, T. A.; Tóth, G.
K. Chem. Soc. Rev. 2006, 35, 323; (b) Fülöp, F. Chem. Rev. 2001, 101, 2181.
10. Bartoli, G.; Cimarelli, C.; Marcantoni, E.; Palmieri, G.; Petrini, M. J. Org. Chem.
1994, 59, 5328.
ˇ
11. Xu, D.; Prasad, K.; Repic, O.; Blacklock, T. J. Tetrahedron: Asymmetry 1997, 8,
1445; See also: Matsuo, J.-i.; Okano, M.; Takeuchi, K.; Tanaka, H.; Ishibashi, H.
Tetrahedron: Asymmetry 2007, 18, 1906.
Acknowledgments
12. For other recent uses of mandelic acid to resolve benzylic amines, see: (a)
Klingensmith, L. M.; Nadeau, K. A.; Moniz, G. A. Tetrahedron Lett. 2007, 48,
4589; (b) Schiffers, I.; Rantanen, T.; Schmidt, F.; Bergmans, W.; Zani, L.; Bolm, C.
J. Org. Chem. 2006, 71, 2320.
The authors thank Drs. David Kucera, Jerry (Lijian) Chen, and
Gregory Haley for many helpful discussions during the course of
this work.
13. No additional attempts were made to more rigorously quantitate the
diastereomeric purity of salts 12 and 15.
References
14. We anticipate that reversing the order in which the mandelic acid enantiomers
are employed in the resolution sequence will allow for the initial isolation of
salt 15 if desired (in lieu of 12).
15. In an independent experiment, the addition of (S)-(+)-mandelic acid to an
EtOAc solution of diastereomerically pure 11 (prepared as described in Scheme
3) resulted in the simultaneous precipitation of both diastereomeric salts
corresponding to 12 and 13. No attempt was made to effect resolution of 11
using other solvents or chiral reagents.
1. Ruebsam, F.; Tran, C. V.; Li, L.-S.; Kim, S. H.; Xiang, A. X.; Zhou, Y.; Blazel, J. K.;
Sun, Z.; Dragovich, P. S.; Zhao, J.; McGuire, H.; Murphy, D. E.; Tran, M. T.;
Stankovic, N.; Ellis, D. A.; Gobbi, A.; Showalter, R. E.; Webber, S. E.; Shah, A. M.;
Tsan, M.; Patel, R.; LeBrun, L. A.; Hou, H. J.; Kamran, R.; Sergeeva, M. V.;
Bartkowski, D. M.; Nolan, T. G.; Norris, D. A.; Kirkovsky, L. Bioorg. Med. Chem.
Lett. 2009, 19, 451.
16. (a) Nativ, E.; Rona, P. Isr. J. Chem. 1972, 10, 55; (b) Parsons, P. J.; Camp, N. P.;
Underhood, J. M.; Harvey, M. D. Tetrahedron 1996, 52, 11637.
2. Tran, C. V.; Ruebsam, F.; Zhou, Y.; Dragovich, P. S.; Xiang, A. X. WO2008/
073982.
17. (a) Zahn, S. K.; Boehmelt, G.; Mantoulidis, A.; Reiser, U.; Treu, M.; Guertler, U.;
Schoop, A.; Solca, F.; Tontsch-Grunt, U.; Brueckner, R.; Reither, C.; Herfurth, L.;
Kraemer, O.; Stadtmueller, H.; Engelhardt, H. US Patent application # 2007/
0032514.; (b) Furrer, H. Chem. Ber. 1972, 105, 2780.
18. We chose not to recover the (S)-(+)-mandelic acid liberated in this step.
However, we anticipate that such a recovery could be accomplished using a
simple process similar to that described in Scheme 3 for the preparation of salt
15.
3. The ephedrine-mediated resolution of racemic Boc-protected cis-2-
aminocyclo-pentanecarboxylic acid has been previously described: Nöteberg,
D.; Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B.; Nillroth, U.;
Danielson, U. H.; Karlén, A.; Hallberg, A. Tetrahedron 1997, 23, 7975.
However, the cost of racemic cis-2-aminocyclopentanecarboxylic acid (ca.
$70/g) and the utilization of several recrystallizations to achieve high
enantiomeric purity precluded us from employing this method to produce
large quantities of 2a and/or 2b.
19. Analytically pure hydrochloride 22 was obtained as an oil rather than the low-
melting solid described in the literature for the (1R,2S)-isomer.7e This
discrepancy likely results from the solvents employed in the preparation of
22, which differ from those utilized in the earlier report and may retard
crystallization when present in trace amounts. The 1H NMR spectrum of 22
was identical to that reported for (1R,2S)-2-amino-cyclopentanecarboxylic acid
ethyl ester hydrochloride. In addition, the specific rotation of the former
material was of equal magnitude but of opposite sign to that reported for the
latter compound [literature data for (1R,2S)-2-aminocyclopentanecarboxylic
4. (a) Bolm, C.; Schiffers, I.; Dinter, C. L.; Gerlach, A. J. Org. Chem. 2000, 65, 6984;
(b) Atodiresei, I.; Schiffers, I.; Bolm, C. Chem. Rev. 2007, 107, 5683.
5. (a) Bolm, C.; Schiffers, I.; Dinter, C. L.; Defrère, L.; Gerlach, A.; Raabe, G. Synthesis
2001, 1719; (b) Bolm, C.; Schiffers, I.; Atodiresei, I.; Hackenberger, C. P. R.
Tetrahedron: Asymmetry 2003, 14, 3455.
6. For large-scale applications of the chemistry described in Refs. 4a and 5, see: (a)
Ishii, Y.; Fujimoto, R.; Mikami, M.; Murakami, S.; Miki, Y.; Furukawa, Y. Org.
Process Res. Dev. 2007, 11, 609; (b) Mittendorf, J.; Benet-Buchholz, J.; Fey, P.;
Mohrs, K.-H. Synthesis 2003, 136.
7. For the preparation of optically active cis-2-aminocyclopentanecarboxylic acid
derivatives via enzymatic resolution, see: (a) Forró, E.; Fülöp, F. Chem. Eur. J.
2007, 13, 6397; (b) Forró, E.; Fülöp, F. Org. Lett. 2003, 5, 1209; (c) Theil, F.;
Ballschuh, S. Tetrahedron: Asymmetry 1996, 7, 3565; (d) Csomós, P.; Kanerva, L.
T.; Bernáth, G.; Fülöp, F. Tetrahedron: Asymmetry 1996, 7, 1789; (e) Kanerva, L.
T.; Csomós, P.; Sundholm, O.; Bernáth, G.; Fülöp, F. Tetrahedron: Asymmetry
1996, 7, 1705.
8. For chemical syntheses of cis-2-aminocyclopentanecarboxylic acid and related
derivatives in optically active form, see: (a) Sakai, T.; Doi, H.; Tomioka, T.
Tetrahedron 2006, 62, 8351; (b) Doi, H.; Sakai, T.; Yamada, K.-i.; Tomioka, T.
Chem. Commun. 2004, 1850–1851; (c) Doi, H.; Sakai, T.; Iguchi, M.; Yamada, K.-
i.; Tomioka, T. J. Am. Chem. Soc. 2003, 125, 2886; (d) Tang, W.; Wu, S.; Zhang, X.
J. Am. Chem. Soc. 2003, 125, 9570; (e) Aggarwal, V. K.; Roseblade, S.; Alexander,
R. Org. Biomol. Chem. 2003, 1, 684; (f) Aggarwal, V. K.; Roseblade, S.; Barrell, J.
K.; Alexander, R. Org. Lett. 2002, 4, 1227; (g) Cimarelli, C.; Palmieri, G.; Volpini,
E. Synth. Commun. 2001, 31, 2943; (h) Cimarelli, C.; Palmieri, G. J. Org. Chem.
acid ethyl ester hydrochloride:7e mp = 68–69.5 °C; ½a 2D0
¼ ꢀ10:4 (c 1.0, EtOH);
ꢂ
1H NMR (400 MHz, CDCl3) d: 1.29 (3H, t, J = 7.1 Hz), 1.65–2.25 (6H, m), 3.02
(1H, dt, J = 8.3, 6.2 Hz), 3.90 (1H, q, J = 5.9 Hz), 4.24 (2H, q, J = 7.1 Hz), 8.50 (3H,
br s)].
20. Optically active trans-2-aminocyclopentanecarboxylic acid esters can be
prepared in good yield by the base-catalyzed isomerization of the
corresponding Boc-protected cis-isomers.8d However, no attempt was made
to use such procedures to isomerize compounds 20 and 23.
21. Preliminary attempts to resolve the cis-isomers of other cyclic b-amino acids
(e.g., 2-aminocyclohexanecarboxylic acid) using the described methodology
were not successful.
22. The use of ‘aged’ CDCl3 in the de-assessments of 12 or 15 often resulted in the
appearance of minor amounts of additional 1H NMR signals. This result is
attributed to the presence of HCl in the CDCl3 that led to the formation of the HCl
salts corresponding to 12 or 15. It is therefore recommend that only relatively
fresh samples of the deuterated NMR solvent be employed for this analysis.